1
|
Wang H, Yang S, Liu J, Fu Z, Liu Y, Zhou L, Guo H, Lan K, Chen Y. Human adenoviruses: A suspect behind the outbreak of acute hepatitis in children amid the COVID-19 pandemic. CELL INSIGHT 2022; 1:100043. [PMID: 37192861 PMCID: PMC10120317 DOI: 10.1016/j.cellin.2022.100043] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Revised: 06/06/2022] [Accepted: 06/06/2022] [Indexed: 05/18/2023]
Abstract
As of 10 May 2022, at least 450 cases of pediatric patients with acute hepatitis of unknown cause have been reported worldwide. Human adenoviruses (HAdVs) have been detected in at least 74 cases, including the F type HAdV41 in 18 cases, which indicates that adenoviruses may be associated with this mysterious childhood hepatitis, although other infectious agents or environmental factors cannot be excluded. In this review, we provide a brief introduction of the basic features of HAdVs and describe diseases caused by different HAdVs in humans, aiming to help understand the biology and potential risk of HAdVs and cope with the outbreak of acute child hepatitis.
Collapse
Affiliation(s)
- Hongyun Wang
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| | - Shimin Yang
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| | - Jiejie Liu
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| | - Zhiying Fu
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| | - Yingle Liu
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| | - Li Zhou
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| | - Haitao Guo
- Department of Microbiology and Molecular Genetics, Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA
| | - Ke Lan
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
- Department of Infectious Diseases, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
| | - Yu Chen
- State Key Laboratory of Virology, Modern Virology Research Center, Institute for Vaccine Research, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, China
| |
Collapse
|
2
|
Mennechet FJD, Paris O, Ouoba AR, Salazar Arenas S, Sirima SB, Takoudjou Dzomo GR, Diarra A, Traore IT, Kania D, Eichholz K, Weaver EA, Tuaillon E, Kremer EJ. A review of 65 years of human adenovirus seroprevalence. Expert Rev Vaccines 2019; 18:597-613. [PMID: 31132024 DOI: 10.1080/14760584.2019.1588113] [Citation(s) in RCA: 95] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Introduction: Human adenovirus (HAdV)-derived vectors have been used in numerous pre-clinical and clinical trials during the last 40 years. Current research in HAdV-based vaccines focuses on improving transgene immunogenicity and safety. Because pre-existing humoral immunity against HAdV types correlate with reduced vaccine efficacy and safety, many groups are exploring the development of HAdV types vectors with lower seroprevalence. However, global seroepidemiological data are incomplete. Areas covered: The goal of this review is to centralize 65 years of research on (primarily) HAdV epidemiology. After briefly addressing adenovirus biology, we chronical HAdV seroprevalence studies and highlight major milestones. Finally, we analyze data from about 50 studies with respect to HAdVs types that are currently used in the clinic, or are in the developmental pipeline. Expert opinion: Vaccination is among the most efficient tools to prevent infectious disease. HAdV-based vaccines have undeniable potential, but optimization is needed and antivector immunity remains a challenge if the same vectors are to be administrated to different populations. Here, we identify gaps in our knowledge and the need for updated worldwide epidemiological data.
Collapse
Affiliation(s)
- Franck J D Mennechet
- a Institut de Génétique Moléculaire de Montpellier , University of Montpellier - CNRS , Montpellier , France
| | - Océane Paris
- a Institut de Génétique Moléculaire de Montpellier , University of Montpellier - CNRS , Montpellier , France
| | - Aline Raissa Ouoba
- a Institut de Génétique Moléculaire de Montpellier , University of Montpellier - CNRS , Montpellier , France.,b UMR 1058, Pathogenesis and Control of Chronic Infections , INSERM - University of Montpellier - Establishment Français du Sang - Centre Hospitalier Universitaire de Montpellier , Montpellier , France.,c Département des sciences et de la recherche clinique , Centre Muraz , Bobo-Dioulasso , Burkina Faso
| | - Sofia Salazar Arenas
- a Institut de Génétique Moléculaire de Montpellier , University of Montpellier - CNRS , Montpellier , France
| | - Sodiomon B Sirima
- d Centre National de Recherche et de Formation sur le Paludisme , Ouagadougou , Burkina Faso.,e Groupe de Recherche Action en Santé (GRAS) , Ouagadougou , Burkina Faso
| | - Guy R Takoudjou Dzomo
- f Complexe Hospitalo Universitaire « Le Bon Samaritain » , N'Djamena , Republic of Chad
| | - Amidou Diarra
- d Centre National de Recherche et de Formation sur le Paludisme , Ouagadougou , Burkina Faso
| | - Isidore T Traore
- c Département des sciences et de la recherche clinique , Centre Muraz , Bobo-Dioulasso , Burkina Faso
| | - Dramane Kania
- c Département des sciences et de la recherche clinique , Centre Muraz , Bobo-Dioulasso , Burkina Faso
| | - Karsten Eichholz
- a Institut de Génétique Moléculaire de Montpellier , University of Montpellier - CNRS , Montpellier , France
| | - Eric A Weaver
- g University of Nebraska-Lincoln, School of Biological Sciences , Lincoln , NE , USA
| | - Edouard Tuaillon
- b UMR 1058, Pathogenesis and Control of Chronic Infections , INSERM - University of Montpellier - Establishment Français du Sang - Centre Hospitalier Universitaire de Montpellier , Montpellier , France
| | - Eric J Kremer
- a Institut de Génétique Moléculaire de Montpellier , University of Montpellier - CNRS , Montpellier , France
| |
Collapse
|
3
|
Yang WX, Zou XH, Jiang SY, Lu NN, Han M, Zhao JH, Guo XJ, Zhao SC, Lu ZZ. Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions. Vaccine 2017; 34:5579-5586. [PMID: 27682509 PMCID: PMC7115419 DOI: 10.1016/j.vaccine.2016.09.043] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2016] [Revised: 09/20/2016] [Accepted: 09/21/2016] [Indexed: 12/16/2022]
Abstract
Serum neutralizing antibodies to Ad5 and Ad41 in adults and children were titrated. Prevalence of NAb in children was associated with age and sanitary conditions. NAb titer distribution pattern was very different between Ad5 an Ad41. Ad41 vectored vaccine candidates might have a bright future.
Neutralizing antibody (NAb) can dampen the immunogenicity of adenovirus (Ad) vector-based vaccine. Vector systems based on human adenovirus type 41 (Ad41) have been constructed and used to develop recombinant vaccines. Here, we attempted to study the seroprevalence of NAbs to Ad5 and Ad41 among children and adults in Qinghai province, China. The positive rates (titer ⩾ 40) of Ad5 and Ad41 NAb in adults from Xining city were 75.7% and 94.7%, respectively. The moderate/high-positive rates (titer ⩾ 160) of NAb were quite close between the two viruses in adults (70.4% for Ad5 and 73.5% for Ad41). Age-dependent increase of NAb seroprevalence was observed for both viruses in children. NAb-positive rate of Ad41 reached 50% at 3.3–4.6 years of age for children from Chengxi district, Xining city, approximately 1.5 years earlier than that of Ad5 did. Interestingly, NAb level was also associated with sanitary conditions among young children. For Ad5, 8–15% children (0.2–3.0 years of age) from city or town, where the sanitations were relatively better, had moderate/high-positive NAb, while the same rate was 62% for children from villages. For Ad41, 22% children from city, 47% from town and 88% from villages possessed moderate/high-positive NAb. The possible influence of NAb titer distributions on the application of Ad41-vectored vaccines was discussed in detail. Our results suggested that children from places with poor sanitations should be included for comprehensive Ad NAb seroprevalence studies, and provided insights to the applications of Ad41 vectors.
Collapse
Affiliation(s)
- Wei-Xiong Yang
- Qinghai Center for Disease Control and Prevention, Xining, Qinghai 810007, China
| | - Xiao-Hui Zou
- State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Shuang-Ying Jiang
- Qinghai Center for Disease Control and Prevention, Xining, Qinghai 810007, China
| | - Nan-Nan Lu
- Qinghai Center for Disease Control and Prevention, Xining, Qinghai 810007, China
| | - Mei Han
- Qinghai Provincial Kangle Hospital, Xining, Qinghai 810006, China
| | - Jian-Hai Zhao
- Qinghai Center for Disease Control and Prevention, Xining, Qinghai 810007, China
| | - Xiao-Juan Guo
- State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Sheng-Cang Zhao
- Qinghai Center for Disease Control and Prevention, Xining, Qinghai 810007, China.
| | - Zhuo-Zhuang Lu
- Qinghai Center for Disease Control and Prevention, Xining, Qinghai 810007, China; State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.
| |
Collapse
|
4
|
Frossard CP, Lazarevic V, Gaïa N, Leo S, Doras C, Habre W, Schrenzel J, Burger D, Eigenmann PA. The farming environment protects mice from allergen-induced skin contact hypersensitivity. Clin Exp Allergy 2017; 47:805-814. [DOI: 10.1111/cea.12905] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Revised: 01/06/2017] [Accepted: 02/08/2017] [Indexed: 12/11/2022]
Affiliation(s)
- C. P. Frossard
- Inflammation and Allergy Research Group; University Hospitals of Geneva and University of Geneva; Geneva Switzerland
| | - V. Lazarevic
- Genomic Research Laboratory; Division of Infectious Diseases; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
- Division of Laboratory Medicine; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - N. Gaïa
- Genomic Research Laboratory; Division of Infectious Diseases; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
- Division of Laboratory Medicine; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - S. Leo
- Genomic Research Laboratory; Division of Infectious Diseases; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
- Division of Laboratory Medicine; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - C. Doras
- Division of Anesthesiology Investigation; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - W. Habre
- Division of Anesthesiology Investigation; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - J. Schrenzel
- Genomic Research Laboratory; Division of Infectious Diseases; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
- Division of Laboratory Medicine; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - D. Burger
- Inflammation and Allergy Research Group; University Hospitals of Geneva and University of Geneva; Geneva Switzerland
- Hans Wilsdorf Laboratory; Departments of Pediatrics, Anesthesiology, and Internal Medicine Specialties; Faculty of Medicine; University of Geneva; Geneva Switzerland
| | - P. A. Eigenmann
- Inflammation and Allergy Research Group; University Hospitals of Geneva and University of Geneva; Geneva Switzerland
| |
Collapse
|